Shanghai, China

Bing Zhou

This inventor holds 6 USPTO granted patents and 7 published patent applications and 8 EPO patents. Top assignees: Chinese Academy of Sciences, Suzhou Suplead Life Sciences Co., Ltd., Suzhou Institute of Materia Medica. Active years: 2021-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bing Zhou. Retrieved from https://idiyas.com/inventor/bing-zhou-0d5lb55z

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 83.3

 

Average Co-Inventor Count = 8.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Certainly! Here is an article about the inventor Bing Zhou:

Title: Innovator Spotlight: Bing Zhou - Pushing Boundaries in Pharmaceutical Research

Introduction:

Bing Zhou, a distinguished inventor based in Shanghai, China, has made significant contributions to the field of pharmaceutical research. With an impressive portfolio of patents, Zhou continues to drive innovation in the development of novel compounds for the treatment of various diseases and disorders.

Latest Patents:

1. Heterocyclic amide for inhibiting RIP1 kinase and uses thereof:

Zhou's groundbreaking invention involves a heterocyclic amide that effectively inhibits RIP1 kinase, offering new possibilities for treating diseases associated with this protein. The compound's versatility and potential for pharmaceutical application mark it as a promising breakthrough in drug discovery.

2. Bromodomain inhibitor compound and use thereof:

In another pioneering patent, Zhou introduces a bromodomain inhibitor compound with wide-ranging implications for therapeutic use. This novel compound, represented by general formula I, showcases Zhou's expertise in developing innovative solutions for complex medical conditions.

Career Highlights:

Zhou has garnered acclaim for his research endeavors at prestigious institutions such as the Shanghai Institute of Materia Medica and the Chinese Academy of Sciences. His tenacity and passion for advancing scientific knowledge have positioned him as a leading figure in the pharmaceutical landscape.

Collaborations:

Throughout his career, Zhou has collaborated with esteemed colleagues, including Cheng Luo and Hualiang Jiang. Together, they have synergized their expertise to bring forth groundbreaking discoveries that have the potential to reshape the future of medicine.

Conclusion:

In conclusion, Bing Zhou's remarkable contributions to pharmaceutical research underscore his unwavering dedication to innovation and scientific excellence. As he continues to forge new paths in drug development, Zhou's impact on the field remains profound and far-reaching, shaping the landscape of modern healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…